HK Stock MarketDetailed Quotes
02162 KEYMED BIO-B
- 42.000
- -0.100-0.24%
Trading Dec 4 10:15 CST
11.75BMarket Cap-14432P/E (TTM)
42.450High41.600Low94.50KVolume42.450Open42.100Pre Close3.97MTurnover0.03%Turnover RatioLossP/E (Static)279.74MShares54.90052wk High4.07P/B11.75BFloat Cap26.60052wk Low--Dividend TTM279.74MShs Float82.850Historical High--Dividend LFY2.02%Amplitude16.900Historical Low41.995Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
KEYMED BIO-B Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | -83.28%54.68M | 253.87%354.1M | 227.12%327.12M | -9.26%100.06M | --100M | --110.27M | ---- | ---- | ---- |
| Operating income | -83.28%54.68M | 253.87%354.1M | 227.12%327.12M | -9.26%100.06M | 100M | 110.27M | |||
| Cost of sales | 75.12%-3.74M | -1,326.62%-36.88M | -491.92%-15.02M | 84.97%-2.59M | ---2.54M | ---17.2M | ---- | ---- | ---- |
| Operating expenses | 75.12%-3.74M | -1,326.62%-36.88M | -491.92%-15.02M | 84.97%-2.59M | -2.54M | -17.2M | |||
| Gross profit | -83.68%50.95M | 225.42%317.22M | 220.23%312.11M | 4.74%97.48M | 97.46M | 93.07M | |||
| Selling expenses | ---23.25M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Administrative expenses | -9.20%-89.95M | -32.18%-177.01M | -61.36%-82.37M | -44.84%-133.91M | -90.22%-51.05M | -329.06%-92.45M | ---26.84M | -42.16%-21.55M | ---15.16M |
| Research and development expenses | -32.54%-331.03M | -17.52%-596.28M | -52.28%-249.76M | -41.66%-507.37M | 14.16%-164.01M | -181.13%-358.16M | ---191.06M | -96.57%-127.4M | ---64.81M |
| Revaluation surplus | ---- | ---- | ---- | ---- | ---- | -399.70%-3.48B | ---3.4B | -616.44%-696.47M | ---97.21M |
| -Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | -399.70%-3.48B | ---3.4B | -616.44%-696.47M | ---97.21M |
| Operating interest expense | ---- | ---- | ---- | ---- | 77.97%-1.33M | ---11.13M | ---6.04M | ---- | ---- |
| Special items of operating profit | -7.90%73.31M | -52.81%121.89M | -38.89%79.6M | 701.51%258.32M | 518.93%130.26M | -205.05%-42.95M | --21.05M | 166.36%40.88M | --15.35M |
| Operating profit | -637.05%-319.96M | -17.06%-334.18M | 425.61%59.58M | 92.66%-285.49M | 100.31%11.34M | -383.74%-3.89B | -3.6B | -397.14%-804.54M | -161.84M |
| Financing cost | 5.07%-8.86M | -105.54%-17.26M | ---9.34M | ---8.4M | ---- | ---- | ---- | -152.05%-14.31M | ---5.68M |
| Share of profit from joint venture company | 19.03%-1.7M | 51.11%-4.75M | 76.20%-2.1M | -1,250.63%-9.71M | ---8.81M | ---719K | ---- | ---- | ---- |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---27.75M | ---- | ---- |
| Earning before tax | -786.52%-330.52M | -17.32%-356.19M | 1,807.49%48.15M | 92.20%-303.6M | 100.07%2.52M | -375.38%-3.89B | -3.63B | -388.83%-818.85M | -167.51M |
| Tax | ---6.08M | ---1.6M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| After-tax profit from continuing operations | -799.14%-336.6M | -17.85%-357.79M | 1,807.49%48.15M | 92.20%-303.6M | 100.07%2.52M | -375.38%-3.89B | -3.63B | -388.83%-818.85M | -167.51M |
| Earning after tax | -799.14%-336.6M | -17.85%-357.79M | 1,807.49%48.15M | 92.20%-303.6M | 100.07%2.52M | -375.38%-3.89B | -3.63B | -388.83%-818.85M | -167.51M |
| Minority profit | -87.95%142K | -65.21%1.57M | 140.20%1.18M | 184.88%4.52M | -51.73%-2.93M | -1,908.68%-5.32M | ---1.93M | ---265K | ---- |
| Profit attributable to shareholders | -816.98%-336.75M | -16.63%-359.36M | 761.15%46.97M | 92.07%-308.12M | 100.15%5.45M | -374.88%-3.89B | -3.63B | -388.67%-818.58M | -167.51M |
| Basic earnings per share | -816.67%-1.29 | -16.10%-1.37 | 765.38%0.18 | 95.12%-1.18 | 100.04%0.0208 | -98.11%-24.17 | -54.08 | -12.2 | |
| Diluted earnings per share | -816.67%-1.29 | -16.10%-1.37 | 782.35%0.18 | 95.12%-1.18 | 100.04%0.0204 | -98.11%-24.17 | -54.08 | -12.2 | |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data
